Antithrombin Cambridge II(A384S) mutation frequency and antithrombin activity levels in 120 of deep venous thrombosis and 150 of cerebral infarction patients in a single center in Southern China

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 6, 2010, Pages 588-591

  Zhang, Guang Sen ^a   Tang, Yang Ming ^a   Tang, Mei Qing ^a   Qing, Zi Ju ^a   Shu, Chang ^a   Tang, Xiang Qi ^a   Deng, Ming Yang ^a   Tan, Li Ming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

antithrombin Cambridge II; antithrombin deficiency; Chinese population; risk factors; thrombosis

Indexed keywords

ANTITHROMBIN; CAMBRIDGE II; UNCLASSIFIED DRUG;

ADULT; AGED; ANTITHROMBIN DEFICIENCY; ARTICLE; BRAIN INFARCTION; CHINA; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG ACTIVITY; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; ANTITHROMBIN III DEFICIENCY; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CHILD; CHINA; CONTINENTAL POPULATION GROUPS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MUTATION; PREVALENCE; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 77955924877     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32833dbe68     Document Type: Article

References (25)

1. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158:585-593.
2. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13:516-530.
3. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68:1370-1373.
4. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74:2082-2088.
5. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85:1504-1508.
6. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 30-untranslated region of the prothrombin gene is associated with clevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703.
7. Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol 1981; 10:369-390.
8. Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med 2002; 126:1326-1336.
9. Bai C, Pan J, Fan L. A study on the deficiency of anticoagulant proteins in Chinese patients with deep venous thrombosis. Chinese J Internal Med 2000; 39:746-748.
10. Corral J, Hernandez-Espinosa D, Soria JM, Gonzalez-Conejero R, Ordonez A, Gonzalez-Porras JR, et al. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. Blood 2007; 109:4258-4263.
11. Roldan V, Ordoñez1 A, Marín F, et al. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost 2009; 101:483-486.
12. Chan LC, Bourke C, Lam CK, Liu HW, Brookes S, Jenkins V, et al. Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors-correlation with absence of Arg506-Gln mutation of factor V gene. Thromb Haemost 1996; 75:522-523.
13. Lu Y, Zhao Y, Liu G, Wang X, Liu Z, Chen B, et al. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res 2002; 106:7-12.
14. Chang JH, Ma Y, Zhang GS. The frequencies of prothrombin G20210A mutation in Chinese the Zhuang nationality population. Chinese Journal of Medical Genetics (Chinese) 2005; 22:341-343.
15. Fujimura HK, Ambayashi J, Monden M, Kato H, Miyata T. Coagulation factor V Leiden mutation may have a racial background. Thromb Haemost 1995; 74:1381-1382.
16. Miyata T, Kawasaki T, Fujimura H, Uchida K, Tsushima M, Kato H. The prothrombin gene G20210A is not found among Japanese patients with deep vein thrombosis and healthy individuals. Blood Coagul Fibrinolysis 1998; 9:451-452.
17. Ishiguro K, Kojima T, Kadomatsu K, Nakayama Y, Takagi A, Suzuki M, et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest 2000; 106:873-878.
18. Sakata T, Okamoto A, Mannami T, Matsuo H, Miyata T. Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese. J Thromb Haemost 2004; 2:528-530.
19. Liu HW, K wong YL, Bourke C, Lam CK, Lie AK, Wei D, et al. High incidence of thrombophilia detected in Chinese patients with venous thrombosis. Thromb Haemost 1994; 71:416-419.
20. Zheng CC, Wu JS, Ding KY, Li JH, He JD, Xiao L, et al. Clinical significance of anticoagulant proteins detection in patients with thrombotic events. Chinese J Hematol 2009; 30:264-267; (Chinese language).
21. Coller BS, Owen J, Jesty J. Deficiency of plasma protein S, protein C or antithrombin III and arterial thrombosis. Arterisclerosis 1987; 7:456-462.
22. Ueyama H, Hashimoto Y, Uchino M, Sasaki Y, Uyama E, Okajima K, et al. Progressing ischemic stroke in a homozygote with variant antithrombin III. Stroke 1989; 20:815-818. (Pubitemid 19168129)
23. Donnet A, Khalil R, Terrier G, Koeppel MC, Njee BT, Aillaud MF, et al. Cerebral infarction, livedo reticularis, and familial deficiency in antithrombin III. Stroke 1992; 23:611-612.
24. Douay X, Lucas C, Caron C, Goudemand J, Leys D. Antithrombin, protein C and Protein S levels in 127 consecutive young adults with ischemic stroke. Acta Neurol Scand 1998; 98:124-127.
25. Tohgi H, Kawashima M, Tamura K, Suzuki H. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Stroke 1990; 21:1663-1667.